Summary
In a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes [MELAS] who had normal mitochondrial enzyme activity, high doses of coenzyme Q10 (CoQ) were administered. Clinical improvement with decreased serum lactate and pyruvate levels was observed. Though the mechanism of action of CoQ is not known, a trial is worthwhile in patients with MELAS.
This is a preview of subscription content, log in via an institution to check access.
References
Folkers K, Wolaniuk A, Vadhanavikit S, Sakamoto N, Takemura K, Baker L, Richardson PC (1984) Biomedical and clinical research on coenzyme Q10 with emphasis on cardiac patients. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q, vol 4. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 375–390
Hart ZH, Chang C-H, Perrin EVW, Neerunjun JS, Ayyar R (1977) Familial poliodystrophy, mitochondrial myopathy and lactate acidemia. Arch Neurol 34:180–185
Hiasa Y, Ishida T, Maeda T, Iwano K, Aihara T, Mori H (1984) Effects of coenzyme Q10 on exercise tolerance in patients with stable angina pectoris. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q, vol 4. Elsevier/North Holland-Biomedical Press, Amsterdam, pp 291–302
Langsjoen PH, Vadhanaviket S, Folkers K (1984) Effective treatment with coenzyme Q10 of patients with myocardial disease class III and IV. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q, vol 4. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 325–332
Morgan-Hughes JA, Hayes DJ, Clark JB, Landon DN, Smash M, Stark RJ, Rudge P (1982) Mitochondrial encephalomyopathies. Biochemical studies in two cases revealing defects in the respiratory chain. Brain 105:553–582
Mortensen SA, Vadhanavikit S, Folkers K (1984) Apparent effectiveness of coenzyme Q10 (CoQ) to treat patients with cardiomyopathy and CoQ levels in blood and endomyocardial biopsies. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q, vol 4. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 391–402
Nayler WG (1980) The use of coenzyme Q10 to protect ischemic heart muscle. In: Yamamura Y, Folkers K, Ito Y (eds) Biomedical and clinical aspects of coenzyme Q, vol 2. Elsevier/North-Holland Biomedical Press, Amsterdam pp 189–204
Ogasahara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T, Nakamura Y, Hashimoto H, Kono N, Tarui S (1985) Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology 35:372–377
Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a distinctive clinical syndrome associated with ragged-red fibers. Ann Neurol 16:481–488
Shapira Y, Cederbaum SD, Cancilla PA, Nielsen D, Lippe BM (1975) Familial poliodystrophy, mitochondrial myopathy and lactic acidemia. Neurology 25:614–621
Skoglund RR (1979) Reversible alexia, mitochondrial myopathy and lactic acidemia. Neurology 29:717–720
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goda, S., Hamada, T., Ishimoto, S. et al. Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy. J Neurol 234, 62–63 (1987). https://doi.org/10.1007/BF00314013
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314013